Yes, hypothyroidism can cause dark circles under the eyes, but it does so indirectly. The thyroid hormone deficit does not pigment the skin itself. It changes blood flow, fluid balance, vessel wall integrity, and sleep architecture, and any of those can darken the thin tissue below the lower lid. In clinical series, a minority of hypothyroid patients report periorbital darkness or puffiness, and most dark circles have other causes.
The periorbital skin is among the thinnest on the body, roughly 0.5 mm in the lower eyelid versus about 2 mm on the cheek. That thinness is why anything happening underneath, from pooled blood to retained fluid, shows through. The question is whether hypothyroidism is one of the things happening underneath. It can be, through four distinct routes, and each route looks slightly different in the mirror. This explainer goes through the mechanisms, the numbers that matter, the cases where the link is weak, and what to do with the information.
The anatomy of the lower-lid shadow
Three structural facts explain why the under-eye area darkens easily. First, the skin is thin enough that the underlying orbicularis oculi muscle and the blood in its capillary bed are visible. Second, the area sits below the orbital rim, where fluid collects when it accumulates anywhere in the face. Third, the skin contains a dense network of small vessels with little subcutaneous fat to mask them. Dark circles are therefore a display of what is underneath: hemoglobin in pooled venous blood, fluid in the tissue, or shadow from a structural groove. True pigment from melanin exists, particularly in darker skin tones, but it is a separate pathway. Hypothyroidism has no direct melanocyte-stimulating action in this region. Any effect it has must run through the vessels, the fluid, or the structures. That distinction matters because it predicts who will improve when thyroid hormone is corrected and who will not.
How low thyroid hormone reaches the eye area
Thyroid hormone affects the vasculature in ways that are easy to trace. Triiodothyronine relaxes vascular smooth muscle and supports endothelial nitric oxide production, so low levels tend to raise systemic vascular resistance and reduce skin perfusion. In hypothyroidism, cardiac output falls and peripheral blood flow is redistributed away from skin. The under-eye area, already thin-skinned and gravity-dependent, becomes a place where slow-flowing blood sits in venules. Deoxygenated hemoglobin absorbs light differently than oxygenated blood, which reads as a blue-gray tint through thin skin. A second route is fluid. Hypothyroidism increases capillary permeability and raises antidiuretic hormone and aldosterone activity, promoting sodium and water retention. Periorbital tissue is loose and compliant, so it is among the first places to show edema. A third route is sleep. Hypothyroidism is associated with obstructive sleep apnea and fragmented sleep, and sleep deprivation independently increases periorbital puffiness and paleness. A fourth route is the vessel wall itself. Thyroid hormone influences the glycosaminoglycan content of soft tissue, and in the extreme form, myxedema, the tissue becomes visibly swollen with a non-pitting quality. That last mechanism is rare and dramatic, but the milder versions of the same process are common. In plain terms, the thyroid sets the tone of the small vessels and the water balance around them.
What the numbers show, and what they do not
Here the evidence gets thinner, and it is worth saying so plainly. No large population study establishes hypothyroidism as a common cause of dark circles. The link rests on clinical observation, small series, and the known physiology above. What the literature does quantify is the prevalence of hypothyroidism itself, which is roughly 4 to 5 percent of the US population, with subclinical disease adding several more percent. The prevalence of periorbital hyperpigmentation in dermatology clinic samples runs much higher, often in the range of one in five to one in four adults, and it is more common in women and in people with darker skin types. Simple arithmetic therefore warns against overattributing. If 5 percent of adults have hypothyroidism and 25 percent have dark circles, most dark circles cannot be thyroid-related even if every hypothyroid patient had them. The more useful framing is diagnostic yield. In a patient with unexplained fatigue, cold intolerance, constipation, and new periorbital puffiness, a thyroid panel is reasonable. In a patient with isolated dark circles and no other symptoms, the pretest probability of hypothyroidism is low, and thyroid testing is unlikely to explain the finding. Overt hypothyroidism with a clearly elevated TSH is more likely to produce visible periorbital changes than subclinical disease with a mildly elevated TSH and normal free T4, because the tissue effects scale with hormone deficit. That gradient is the practical takeaway.
Edge cases and the counterintuitive detail
The most important caveat is that hypothyroidism and its mimics do not all darken the same way. The classic thyroid-associated periorbital change is puffiness and pallor, not brown pigment. A patient whose dark circles are truly brown or bronze, especially with a family history and onset in childhood, is far more likely to have periorbital melanosis than a thyroid problem. A second edge case is thyroid eye disease, which occurs in Graves disease, an autoimmune hyperthyroid condition, and not in typical hypothyroidism. Graves eye disease causes proptosis, lid retraction, and a hollowed, shadowed look from tissue remodeling, and it can coexist with Hashimoto thyroiditis in the same patient at different times. A third edge case is the patient whose hypothyroidism is well treated. Once TSH is normalized and free T4 is adequate, any residual dark circles are almost certainly structural or pigmentary, and raising the dose further does not address them. The counterintuitive point is that the anemia that often accompanies hypothyroidism may matter more than the thyroid hormone itself for periorbital color. Iron deficiency and vitamin B12 deficiency both reduce hemoglobin and produce pallor and shadowing that mimic or amplify dark circles, and both are more common in hypothyroid populations. In some patients, correcting the anemia changes the under-eye appearance more than correcting the TSH. That is a professional caveat worth carrying: the treatable driver may be adjacent to the diagnosis, not the diagnosis itself.
Where the hypothesis breaks down
Several observations should temper confidence in the thyroid explanation. Dark circles persist in most hypothyroid patients after months of adequate levothyroxine replacement, which suggests the structural and pigmentary components dominate over time. Seasonal and sleep-related variation in dark circles is larger in most people than any plausible thyroid contribution. Periorbital edema from hypothyroidism tends to be bilateral and symmetric and accompanied by facial puffiness elsewhere, whereas isolated under-eye darkness without facial involvement is unlikely to be thyroidal. And there is a threshold problem in the other direction: severe hypothyroidism can cause myxedema of the face and lids, but in that state the patient is generally symptomatic enough that the eye finding is not the presenting complaint. Reconciling the thresholds is straightforward. Overt hypothyroidism, defined as a TSH above the reference limit with a low free T4, is the scenario with real mechanistic plausibility for periorbital change. Subclinical hypothyroidism, defined as TSH mildly elevated with a normal free T4, carries much weaker plausibility, and treatment decisions there are made on other grounds. The dark circles hypothesis does not justify treating subclinical disease by itself.
Practical actions and red flags
Start with observation and history before testing. Note whether the darkness is blue-gray (vascular), brown (pigmentary), or caused by a visible groove (structural), because the three respond differently. Ask about sleep duration, snoring, and daytime sleepiness to screen for the sleep apnea link. Ask about cold intolerance, weight change, constipation, and dry skin to screen for hypothyroidism itself. If two or more thyroid symptoms are present, obtain a TSH with reflex free T4, and add a complete blood count and ferritin if pallor is prominent.
For confirmed hypothyroidism, the lever is adherence and dose adequacy. A TSH in the reference range on a stable dose is the goal, and dose adjustment is a clinician's decision, not a self-directed one. Expect periorbital puffiness to improve over weeks to a few months, and expect pigmentary dark circles not to change at all.
Seek medical evaluation promptly for these warning signs:
Eyelid or facial swelling that is new, painful, or asymmetric Bulging eyes, double vision, or eye pain, which suggest thyroid eye disease A rapidly enlarging neck mass or difficulty swallowing or breathing Dark circles with unexplained weight loss, palpitations, or heat intolerance, which point the other way, toward hyperthyroidism Severe fatigue with pallor, shortness of breath, or restless legs, which suggest anemia Cold intolerance with deepening voice, slowed thinking, or facial swelling, which suggest overt hypothyroidism
Vessels, fluid, pigment, or shadow: what each pattern suggests
| Under-eye pattern | Appearance | Likely mechanism | Thyroid link | What to expect after thyroid correction |
|---|---|---|---|---|
| Vascular | Blue-gray, worse with fatigue and cold | Pooled deoxygenated blood in thin skin | Indirect, via reduced skin perfusion | Partial improvement if overt disease |
| Fluid | Bilateral puffiness, worse in the morning | Capillary leak and sodium retention | Moderate in overt hypothyroidism | Puffiness often improves over weeks |
| Pigmentary | Brown or bronze, symmetric, family history | Melanin deposition | None direct | No change |
| Structural | Visible groove or hollow under the rim | Tear trough, fat loss, bone contour | None | No change |
| Shadow from laxity | Dark band at the lid-cheek junction | Skin and soft tissue descent | None | No change |
| Mixed | Dark plus puffy plus hollow | All of the above | Weak, per case | Modest at best |
The table is a diagnostic aid, not a rule. Most people have a mixed pattern, which is why isolated dark circles rarely have a single cause.
Timeline: what changes and when
| Time point | What is happening | What to watch |
|---|---|---|
| Before diagnosis | Tissue effects of low hormone accumulate | New puffiness, fatigue, cold intolerance |
| 0 to 2 weeks on levothyroxine | TSH begins to fall, but tissues lag | Little visible change expected |
| 4 to 6 weeks | TSH rechecked, dose adjusted if needed | Serum markers move before the face does |
| 6 to 12 weeks | Skin perfusion and fluid balance improve | Early reduction in puffiness |
| 3 to 6 months | Euthyroid state usually achieved | Residual darkness now likely structural or pigmentary |
| Beyond 6 months | Stable dosing | No further improvement in dark circles expected |
| Anytime, if anemia coexists | Iron and B12 repletion proceeds on its own timeline | Pallor may change before color does |
The two timelines, serum and skin, do not run in parallel. The blood test normalizes first, and the mirror follows slowly, if at all.
Limitations of the evidence
The honest summary is that the question has mechanistic support but thin direct evidence. The pathways linking hypothyroidism to periorbital vascular pooling, fluid retention, and sleep disruption are well established physiology. The claim that treating hypothyroidism reliably reduces dark circles is not established in controlled studies, and no trial has used periorbital pigmentation as an endpoint. Some of what is written about "thyroid facies" comes from older clinical descriptions rather than modern measurement. The contribution of coexisting anemia is plausible and common but not quantified for this specific outcome. The correct conclusion is proportionate. Hypothyroidism belongs on the differential for new periorbital puffiness and shadowing in a patient with other thyroid symptoms, and it should be ruled in or out with a TSH and free T4 in that setting. It does not belong on the differential for isolated dark circles in an otherwise well person, and treating it as the default explanation leads to unnecessary testing and disappointment. Dark circles are mostly anatomy, sleep, and pigment. The thyroid can add to that picture, but it is rarely the whole picture.